Daesung Microbiological Labs. Co. Ltd (KQ:036480) — Market Cap & Net Worth
Market Cap & Net Worth: Daesung Microbiological Labs. Co. Ltd (036480)
Daesung Microbiological Labs. Co. Ltd (KQ:036480) has a market capitalization of $18.95 Million (₩27.97 Billion) as of May 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25194 globally and #1877 in its home market, demonstrating a -0.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daesung Microbiological Labs. Co. Ltd's stock price ₩7360.00 by its total outstanding shares 3800000 (3.80 Million). Analyse cash flow conversion of Daesung Microbiological Labs. Co. Ltd to see how efficiently the company converts income to cash.
Daesung Microbiological Labs. Co. Ltd Market Cap History: 2015 to 2026
Daesung Microbiological Labs. Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $21.32 Million to $18.95 Million (-3.52% CAGR).
Index Memberships
Daesung Microbiological Labs. Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$306.89 Billion | 0.01% | #1017 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$306.89 Billion | 0.01% | #1017 of 1384 |
Weight: Daesung Microbiological Labs. Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Daesung Microbiological Labs. Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daesung Microbiological Labs. Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Daesung Microbiological Labs. Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $21.32 Million | $31.03 Billion | $4.55 Billion | 0.00x | 0.00x |
| 2016 | $31.49 Million | $30.80 Billion | $4.49 Billion | 0.00x | 0.01x |
| 2017 | $26.36 Million | $24.04 Billion | $1.56 Billion | 0.00x | 0.02x |
| 2018 | $43.96 Million | $25.10 Billion | $3.17 Billion | 0.00x | 0.01x |
| 2019 | $39.93 Million | $25.13 Billion | $2.85 Billion | 0.00x | 0.01x |
| 2020 | $40.91 Million | $24.80 Billion | $1.52 Billion | 0.00x | 0.03x |
| 2021 | $36.44 Million | $24.00 Billion | $865.92 Million | 0.00x | 0.04x |
| 2022 | $26.35 Million | $25.50 Billion | $1.70 Billion | 0.00x | 0.02x |
| 2023 | $28.20 Million | $25.56 Billion | -$679.68 Million | 0.00x | N/A |
| 2024 | $23.41 Million | $23.80 Billion | -$1.77 Billion | 0.00x | N/A |
Competitor Companies of 036480 by Market Capitalization
Companies near Daesung Microbiological Labs. Co. Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Daesung Microbiological Labs. Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $109.06 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #357 globally with a market cap of $73.69 Billion USD.
- UCB SA (BR:UCB): Ranked #519 globally with a market cap of $50.85 Billion USD ( €43.50 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #567 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $109.06 Billion | $429.85 |
| #357 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.69 Billion | $709.21 |
| #519 | UCB SA | BR:UCB | $50.85 Billion | €228.50 |
| #567 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Daesung Microbiological Labs. Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Daesung Microbiological Labs. Co. Ltd's market cap moved from $21.32 Million to $ 18.95 Million, with a yearly change of -3.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩18.95 Million | +0.82% |
| 2025 | ₩18.80 Million | -19.69% |
| 2024 | ₩23.41 Million | -16.99% |
| 2023 | ₩28.20 Million | +7.04% |
| 2022 | ₩26.35 Million | -27.70% |
| 2021 | ₩36.44 Million | -10.93% |
| 2020 | ₩40.91 Million | +2.45% |
| 2019 | ₩39.93 Million | -9.16% |
| 2018 | ₩43.96 Million | +66.75% |
| 2017 | ₩26.36 Million | -16.30% |
| 2016 | ₩31.49 Million | +47.72% |
| 2015 | ₩21.32 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Daesung Microbiological Labs. Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.95 Million USD |
| MoneyControl | $18.95 Million USD |
| MarketWatch | $18.95 Million USD |
| marketcap.company | $18.95 Million USD |
| Reuters | $18.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Daesung Microbiological Labs. Co. Ltd
Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in U… Read more